CMPX vs CSGP · $367.4M cap vs P/E 484, rev $2.74B
Compass Therapeutics Inc. (CMPX) versus CoStar Group Inc (CSGP) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
CMPX currently screens at market cap $367.4M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Not investment advice. Open the CMPX and CSGP stock pages for the full models.
Not investment advice.